Myriad Genetics, Inc. is a company in the U.S. stock market and it is a holding in 74 U.S.-traded ETFs. MYGN has around 16.9M shares in the U.S. ETF market. The largest ETF holder of MYGN is the iShares Core S&P Small-Cap ETF (IJR), with approximately 4.62M shares. Investors may also find of interest that the ETF with the largest allocation to MYGN stock is Invesco Dynamic Biotechnology & Genome ETF (PBE), with a portfolio weight of 2.03%. On average, U.S. ETFs allocate 0.15% of MYGN to their portfolios.
Additionally, MYGN is a favorite stock for Vanilla and Multi-factor ETFs. It is also most likely to belong to Broad-based ETFs. The best-performing ETF in the past 12 months with MYGN as a holding is the ProShares Ultra NASDAQ Biotechnology (BIB), with a return of 39.80%.